Welcome to LookChem.com Sign In|Join Free
  • or
3,5-Pyridinedicarboxylic acid, mono(phenylmethyl) ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

192518-50-6

Post Buying Request

192518-50-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

192518-50-6 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 192518-50-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,2,5,1 and 8 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 192518-50:
(8*1)+(7*9)+(6*2)+(5*5)+(4*1)+(3*8)+(2*5)+(1*0)=146
146 % 10 = 6
So 192518-50-6 is a valid CAS Registry Number.

192518-50-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-phenylmethoxycarbonylpyridine-3-carboxylate

1.2 Other means of identification

Product number -
Other names 3,5-Pyridinedicarboxylic acid,mono(phenylmethyl) ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:192518-50-6 SDS

192518-50-6Relevant academic research and scientific papers

4,6-DISUBSTITUTED PYRIMIDINES AND THEIR USE AS PROTEIN KINASE INHIBITORS

-

Page/Page column 58, (2008/06/13)

The invention relates to novel pyrimidine derivatives of Formula (I), which are efficacious inhibitors of protein kinases, in particular of one or more isoforms of the protein kinase B/Akt.

PYRROLOPYRIDAZINE DERIVATIVES

-

Page 185, (2008/06/13)

The invention relates to compound of the formula (I) or its salt, in which R1, R2, R3 and R4 are as defined in the description, their use of as medicament, the process for their preparation and use for the treatment of PDE-IV or TNF-α mediated diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 192518-50-6